April 16, 2019
April 16, 2019
PHILADELPHIA-(PR NEWSWIRE)-Integral Molecular, the industry leader in membrane protein solutions, today announced the expansion of its two proprietary antibody characterization platforms, Shotgun Mutagenesis Epitope Mapping and […]
March 26, 2019
March 26, 2019
PHILADELPHIA-(PR NEWSWIRE)-Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, will showcase updated data on its discovery of highly specific Claudin 6 MAbs […]
January 7, 2019
January 7, 2019
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in membrane protein solutions, today announced that it has entered into a collaboration to discover new therapeutic targets in immuno-oncology […]
January 3, 2019
January 3, 2019
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against multipass membrane proteins, and Ono Pharmaceutical Co., Ltd. today announced that they […]
December 4, 2018
December 4, 2018
PHILADELPHIA–(PR NEWSWIRE)–Integral Molecular, the industry leader in antibody discovery against multipass membrane proteins, was awarded $1.4M by the NIH to develop its lead antibodies against cannabinoid […]
November 1, 2018
November 1, 2018
PHILADELPHIA–(BUSINESS WIRE)–Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research (SBIR) grant from the NIH to initiate a target […]
September 18, 2018
September 18, 2018
PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage […]
June 1, 2018
June 1, 2018
PHILADELPHIA-(BUSINESS WIRE)-Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, celebrates a milestone of mapping 1,000 epitopes for customers, collaborators, […]
May 30, 2018
May 30, 2018
Integral Molecular, the industry leader in membrane protein antibody discovery, announces the development of antibody assets targeting membrane proteins important in oncology (Claudin 6) and metabolic […]
March 13, 2018
March 13, 2018
PHILADELPHIA–(BUSINESS WIRE)-Integral Molecular, the industry leader in engineering membrane proteins, has extended its protein engineering capabilities to stabilize viral proteins and produce more effective candidate vaccines […]
December 21, 2017
December 21, 2017
PHILADELPHIA–(BUSINESS WIRE)– Integral Molecular, the industry leader in the expression and characterization of multipass membrane proteins, has expanded its mapping capabilities to include small molecules. This […]
September 6, 2017
September 6, 2017
PHILADELPHIA (September 6, 2017) – A new kind of interdisciplinary artistic collaboration is happening in Philadelphia this fall. The University City Science Center has partnered with […]
August 30, 2017
August 30, 2017
PHILADELPHIA-(BUSINESS WIRE)-Integral Molecular, a Philadelphia based biotechnology company, announces the expansion of its facility, personnel, and resources dedicated to antibody discovery for membrane protein targets. The […]
June 15, 2017
June 15, 2017
PHILADELPHIA-(BUSINESS WIRE)-Integral Molecular, a leader in membrane protein technologies, has initiated a therapeutic target discovery program in immuno-oncology by exploiting its Membrane Proteome Array technology to […]
June 7, 2017
June 7, 2017
PHILADELPHIA–Integral Molecular announces the expansion of its proprietary Membrane Proteome Array™ to now consist of 5,300 unique human membrane proteins, representing nearly the entire human membrane […]
May 18, 2017
May 18, 2017
ROCKVILLE, Md., May 18, 2017 /PRNewswire/ — In research published online today in Cell, a team of scientists describe an antibody called CA45, elicited by immunization […]
March 2, 2017
March 2, 2017
Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery
Philadelphia, PA & Rockville, MD. (BUSINESSWIRE) March 2, 2017 —Integral Molecular and Integrated BioTherapeutics have teamed up in the fight against the global health crises posed […]
November 16, 2016
November 16, 2016
Integral Molecular Isolates Zika-Specific Monoclonal Antibodies for Vaccine Research and Diagnostics
PHILADELPHIA — Integral Molecular announces the isolation of neutralizing monoclonal antibodies specific for the Zika virus envelope, thereby enabling vital vaccine research and the development of […]
November 7, 2016
November 7, 2016
Administering a human antibody that neutralizes Zika virus to pregnant mice before or after Zika virus infection reduced levels of the virus in placental and fetal […]
September 21, 2016
September 21, 2016
Integral Molecular announces the launch of the Membrane Proteome Array (MPA), a rapid and reliable platform for de-risking therapeutic development by profiling the target specificity of […]